[ Price : $8.95]
FDA approves a Reckitt Benckiser Pharmaceuticals NDA for Suboxone (buprenorphine HCl/naloxone HCl dihydrate) sublingual film, indi...[ Price : $8.95]
FDA extends by 90 days its review of a Valeant Pharmaceuticals NDA for Potiga (ezogabine) in order to review a recently requested ...[ Price : $8.95]
FDA cracks down on Chinese eyeglass imports that fail to meet required impact-resistance tests, after finding 38-100% broke comple...[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Bristol-Myers Squibbs Onglyza for the purpose of patent e...[ Price : $8.95]
FDA accepts for filing and gives priority review status to Alimera Sciences Illuvien NDA.[ Price : $8.95]
Members of Congress say a new GAO reports shows that FDA needs to do more to ensure that non-inferiority trials adequately evaluat...[ Price : $8.95]
Federal Register Notice: FDA makes available supplemental grant funds for Food Emergency Response Laboratory Network microbiologic...[ Price : $8.95]
Nanotherapeutics files an IND with FDA for NanoDTPA, an oral capsule indicated to remove radioactive compounds from the body and h...